OmniComm Systems, a global provider of clinical data management solutions for clinical trials, signed a five-year agreement with Seoul National University Hospital (SNUH) Clinical Trials Center, an academic medical center in the Republic of Korea, to use OmniComm Systems' TrialOne technology for automation within its phase I clinical pharmacology studies.
SNUH conducted an evaluation with a specific emphasis on subject recruitment, study data capture, sample tracking, reporting, data management and integration with laboratory and medical monitoring equipment and found TrialOne superior in all categories when compared to other commercially available technologies. The depth in functionality and foreign language capabilities were a significant factor in the decision.
"TrialOne will greatly improve our research environment," said prof. Yung-Jue Bang, M.D., Ph.D., president Biomedical Research Institute SNUH and director SNUH Clinical Trials Center. "Not only will it automate many study activities, but it also will upgrade our clinical trials system by enabling more streamlined work flows. This will lead to a drastic increase in the quality of clinical trials and their related services to our valued clients."
"This is the first customer for TrialOne in Asia, but certainly not the last," said Wolf Ondracek, senior vice president Academic and Asian Markets, OmniComm Systems. "Seoul National University ranks high in all the international university rankings, and their hospital is one of the leading medical centers in the East-Asia region and a top medical institute in Korea. In 2012, SNUH Clinical Trials Center was selected as a Global Center of Excellence in Early Phase Clinical Trials by the Korean Ministry of Health and Welfare. Their ambition is to become one of the leading early phase clinical trials centers in the world by 2022 and we are proud that our TrialOne solution will be an important tool to achieve that goal."